CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+30.75%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$904M
AUM Growth
+$904M
(+6.5%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
84.52%
Holding
24
New
4
Increased
4
Reduced
9
Closed
4
Top Buys
| 1 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$94.1M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$61.1M |
| 3 |
Pacira BioSciences
PCRX
|
$51.8M |
| 4 |
Travere Therapeutics
TVTX
|
$26.6M |
| 5 |
Pacific Biosciences
PACB
|
$16.1M |
Top Sells
| 1 |
AtriCure
ATRC
|
$69.1M |
| 2 |
Globus Medical
GMED
|
$67.8M |
| 3 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$66.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$51M |
| 5 |
Myriad Genetics
MYGN
|
$46.8M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
1
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $123M | 13.55% | 8,709,131 +6,688,548 | +331% | +$94.1M |
|
|
2
Travere Therapeutics
TVTX
$1.56B
| $87.3M | 9.65% | 3,505,604 +1,067,064 | +44% | +$26.6M |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $86.3M | 9.54% | 24,649,280 -175,000 | -0.7% | -$612K |
|
4
PTC Therapeutics
PTCT
$3.92B
| $79M | 8.73% | 3,946,009 | – | – |
|
5
Corcept Therapeutics
CORT
$7.35B
| $74.9M | 8.29% | 3,882,223 -1,922,117 | -33% | -$37.1M |
|
|
6
Myriad Genetics
MYGN
$593M
| $71.4M | 7.9% | 1,973,177 -1,294,310 | -40% | -$46.8M |
|
|
LJPC
7
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $69.6M | 7.7% | 2,002,519 -10,000 | -0.5% | -$348K |
|
|
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $61.1M | 6.76% | +602,047 | New | +$61.1M |
|
|
AAAP
9
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $60.2M | 6.66% | 890,935 -978,572 | -52% | -$66.2M |
|
|
10
Pacira BioSciences
PCRX
$1.2B
| $51.8M | 5.73% | +1,380,134 | New | +$51.8M |
|
|
KERX
11
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $37.1M | 4.11% | 5,229,455 -1,775,586 | -25% | -$12.6M |
|
|
12
Pacific Biosciences
PACB
$393M
| $36.2M | 4.01% | 6,901,428 +3,068,715 | +80% | +$16.1M |
|
13
Vericel Corp
VCEL
$1.83B
| $18.1M | 2.01% | 3,024,334 +458,250 | +18% | +$2.75M |
|
|
CVRS
14
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $18M | 1.99% | 11,863,353 -3,251,519 | -22% | -$4.94M |
|
|
15
Globus Medical
GMED
$8.27B
| $16.5M | 1.82% | 554,699 -2,280,301 | -80% | -$67.8M |
|
16
ANI Pharmaceuticals
ANIP
$2.03B
| $7.51M | 0.83% | 143,003 | – | – |
|
17
ADMA Biologics
ADMA
$4.12B
| $3.92M | 0.43% | 1,273,933 | – | – |
|
|
STML
18
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.13M | 0.12% | +101,420 | New | +$1.13M |
|
19
Catalyst Pharmaceutical
CPRX
$2.52B
| $931K | 0.1% | +369,298 | New | +$931K |
|
|
SPNE
20
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $489K | 0.05% | 43,627 -10,000 | -19% | -$112K |
|
|
21
AtriCure
ATRC
$1.84B
| – | – | -2,849,185 | Closed | -$69.1M |
|
|
BIOL
22
DELISTED
Biolase, Inc.
BIOL
| – | – | -1,152,737 | Closed | -$1.12M |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | -544,843 | Closed | -$51M |
|
|
SBBP
24
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – | -10,000 | Closed | -$72K |
|